
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Nattokinase is a fibrinolytic enzyme derived from natto (fermented soybeans) that directly breaks down fibrin to support cardiovascular health. The enzyme works by cleaving fibrin clots and activating plasminogen, promoting healthy blood circulation and reducing thrombotic risk.

Reported Benefits (Provisional)
Origin & History

Nattokinase is an enzyme derived from natto, a traditional Japanese food made from fermented soybeans. It is produced through the fermentation process involving the bacterium Bacillus subtilis var. natto.
Research Narrative (Provisional)
Clinical trials and observational studies support its role in cardiovascular health, particularly in promoting blood flow and reducing clot formation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains fibrinolytic activity, aiding in blood clot breakdown. - Rich in protein due to its soybean origin. - Contains vitamin K2, important for bone and cardiovascular health.
Reported Mechanism (Provisional)
Nattokinase directly cleaves fibrin through its serine protease activity, breaking down existing blood clots and preventing new clot formation. The enzyme also activates tissue plasminogen activator (tPA) and converts plasminogen to plasmin, enhancing the body's natural fibrinolytic system. Additionally, nattokinase inhibits plasminogen activator inhibitor-1 (PAI-1), further promoting clot dissolution.
Clinical Narrative (Provisional)
Human studies using 2000-6000 FU (fibrinolytic units) daily have demonstrated nattokinase's ability to reduce blood viscosity by 8-12% and improve circulation markers within 2-8 weeks. A randomized controlled trial with 86 participants showed significant reductions in fibrinogen levels and improved arterial elasticity after 8 weeks of supplementation. Several smaller studies have reported decreased blood pressure and improved lipid profiles, though larger long-term trials are needed to confirm cardiovascular protection. The evidence is promising but still emerging, with most studies having 12-week durations and moderate sample sizes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







